2022
DOI: 10.1007/s40121-022-00620-0
|View full text |Cite
|
Sign up to set email alerts
|

Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review

Abstract: Invasive meningococcal disease (IMD) outbreaks associated with Hajj and Umrah pilgrimage events in the Kingdom of Saudi Arabia (KSA) are well recognized. Past outbreaks have been associated with substantial intercontinental spread of specific Neisseria meningitidis serogroups. The emergence of meningococcal serogroup W (MenW) was a global concern following the 2000/2001 Hajj outbreaks. Broader compulsory meningococcal serogroups A, C, W and Y (MenACWY) immunization S. Badur (&) EM, Vaccines Scientific Affairs … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(20 citation statements)
references
References 102 publications
(199 reference statements)
0
19
0
Order By: Relevance
“… 3–9 Vaccination against N. meningitidis with a quadrivalent (serogroup A, C, W, and Y) conjugate vaccine (MCV4) is recommended for children and adolescents in many countries, as well as for those at increased risk of the disease due to occupation or travel to endemic areas. 10–12 In particular, the Hajj pilgrimage to Mecca has been associated with outbreaks of meningococcal disease among travelers who have returned to their home countries 13 , 14 and therefore the Kingdom of Saudi Arabia requires visitors going on Hajj or Umrah to submit a valid vaccination certificate indicating receipt of either a quadrivalent polysaccharide meningococcal vaccine within the last 3 years, or a quadrivalent conjugate vaccine within the last 5 years. 10 , 14 , 15 This requirement stems from evidence demonstrating that protection following MCV4 vaccination may wane 3–5 years after primary vaccination.…”
Section: Introductionmentioning
confidence: 99%
“… 3–9 Vaccination against N. meningitidis with a quadrivalent (serogroup A, C, W, and Y) conjugate vaccine (MCV4) is recommended for children and adolescents in many countries, as well as for those at increased risk of the disease due to occupation or travel to endemic areas. 10–12 In particular, the Hajj pilgrimage to Mecca has been associated with outbreaks of meningococcal disease among travelers who have returned to their home countries 13 , 14 and therefore the Kingdom of Saudi Arabia requires visitors going on Hajj or Umrah to submit a valid vaccination certificate indicating receipt of either a quadrivalent polysaccharide meningococcal vaccine within the last 3 years, or a quadrivalent conjugate vaccine within the last 5 years. 10 , 14 , 15 This requirement stems from evidence demonstrating that protection following MCV4 vaccination may wane 3–5 years after primary vaccination.…”
Section: Introductionmentioning
confidence: 99%
“…The high proportion of non-citizen workers in GCC Countries, and the often-substantial proportion of IMD cases involving non-citizen residents is such that a top-level appraisal of local IMD epidemiology in worker origin countries is relevant (in particular as a high proportion of pilgrims attending Hajj/Umrah events within SA also originate from these countries). 56 Although surveillance is often inconsistent, low-level endemic IMD exists in most Asian worker origin countries (i.e., India, Pakistan, Bangladesh, Nepal, Sri Lanka and the Philippines) and in other Arab countries (e.g., Egypt, Syria and Yemen) and N. meningitidis is an important cause of bacterial meningitis in all. 56 With the exception of Egypt (where infant polysaccharide MenA-C vaccination has been available since 1992), most countries have no formal meningococcal immunization policy.…”
Section: Imd Epidemiology In Gcc Countriesmentioning
confidence: 99%
“… 56 Although surveillance is often inconsistent, low-level endemic IMD exists in most Asian worker origin countries (i.e., India, Pakistan, Bangladesh, Nepal, Sri Lanka and the Philippines) and in other Arab countries (e.g., Egypt, Syria and Yemen) and N. meningitidis is an important cause of bacterial meningitis in all. 56 With the exception of Egypt (where infant polysaccharide MenA-C vaccination has been available since 1992), most countries have no formal meningococcal immunization policy. In India, although surveillance data is limited, and IMD under-reported, historic outbreaks associated with MenA are well-reported, 57 , 58 and a low level of endemic disease due to other serogroups (MenB, C, Y and W) is also observed.…”
Section: Imd Epidemiology In Gcc Countriesmentioning
confidence: 99%
See 2 more Smart Citations